Pulmonx Corp (LUNG)

$3.09 +0.18 (6.19%)
Market Cap 108.70M
Revenue (ttm) 83.79M
Net Income (ttm) -56.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -67.30%
Debt to Equity Ratio 0.48
Volume 666,300
Avg Vol 364,906
Day's Range N/A - N/A
Shares Out 40.26M
Stochastic %K 70%
Beta 0.45
Analysts Strong Sell
Price Target $11.59

Company Profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography a...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 364 0400
Website: pulmonx.com
Address:
700 Chesapeake Drive, Redwood City, United States
RocketThief
RocketThief Jul. 17 at 2:13 PM
$LUNG let her cook
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 16 at 9:35 PM
$LUNG earnings JULY 30
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 15 at 5:21 PM
$LUNG MASSIVE BID!!
0 · Reply
SAS080
SAS080 Jul. 14 at 6:36 PM
$LUNG added
0 · Reply
Jpextreme1
Jpextreme1 Jul. 14 at 4:53 PM
$LUNG Adds
0 · Reply
Raxothus
Raxothus Jul. 14 at 3:21 PM
EOD FOLLOW-UP – 07/14/25 Tracking continuation watch from 07/11 based on today’s highs vs prior close ✅ $DARE – Closed 2.51, hit 10.40 HOD ✅ $UAVS – Closed 1.57, hit 1.85 HOD ✅ $ZENA – Closed 5.03, hit 5.67 HOD ✅ $LUNG – Closed 2.91, hit 3.09 HOD ❌ $NMI – Closed 10.56, hit 10.49 HOD, then faded Recap Total: 5 Winners: 4 Faders: 1 Accuracy: 80% Strong continuation across the board Four out of five delivered clean range with volume Setups rewarded VWAP prep and patience from the prior session It won’t always be this clean — but we prep with purpose, wait for structure, and let the edge play out No guessing, no hope trades — just sniper-level execution #VWAP #SniperSetup #Continuation #SmallCaps #Accountability #DayTrading
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 14 at 1:00 PM
$LUNG looking to cross $3.00 soon with $3.12 the next major resistance🚨🚨
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 13 at 1:36 PM
$LUNG some AERISEAL news would be huge
2 · Reply
RocketThief
RocketThief Jul. 11 at 8:39 PM
$LUNG stay tuned
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 11 at 8:18 PM
$LUNG sec filings from Ferrari just hit
0 · Reply
Latest News on LUNG
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Jul 16, 2025, 4:05 PM EDT - 1 day ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 7 weeks ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

May 1, 2025, 4:05 PM EDT - 2 months ago

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 8:25 PM EDT - 2 months ago

Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript

Pulmonx Reports First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 2 months ago

Pulmonx Reports First Quarter 2025 Financial Results

EDAP Appoints Glen French to Board of Directors

Mar 3, 2025, 7:00 AM EST - 4 months ago

EDAP Appoints Glen French to Board of Directors

EDAP

Top 3 Health Care Stocks You May Want To Dump In February

Feb 20, 2025, 3:50 PM EST - 5 months ago

Top 3 Health Care Stocks You May Want To Dump In February

MD SWTX

Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 7:40 PM EST - 5 months ago

Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 19, 2025, 4:05 PM EST - 5 months ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Feb 13, 2025, 4:05 PM EST - 5 months ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Feb 5, 2025, 4:05 PM EST - 5 months ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 8 months ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 19, 2024, 9:00 AM EST - 8 months ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Nov 5, 2024, 4:05 PM EST - 9 months ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 6:54 AM EDT - 9 months ago

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Oct 16, 2024, 4:05 PM EDT - 9 months ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Sep 9, 2024, 4:05 PM EDT - 11 months ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 29, 2024, 4:05 PM EDT - 11 months ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Aug 22, 2024, 4:05 PM EDT - 11 months ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 10:33 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Reports Second Quarter 2024 Financial Results

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Pulmonx: Low Bar For Q2 Earnings

Jul 21, 2024, 9:00 AM EDT - 1 year ago

Pulmonx: Low Bar For Q2 Earnings

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Jul 10, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 6, 2024, 5:03 PM EDT - 1 year ago

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

May 1, 2024, 9:08 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

Pulmonx Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Reports First Quarter 2024 Financial Results

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 10, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Apr 2, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 26, 2024, 8:00 AM EST - 1 year ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 9:01 PM EST - 1 year ago

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:06 PM EST - 1 year ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 21, 2024, 4:05 PM EST - 1 year ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Feb 7, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

The Prognosis For Pulmonx Corporation

Nov 8, 2023, 12:01 PM EST - 1 year ago

The Prognosis For Pulmonx Corporation

Pulmonx to Participate at Upcoming Investor Conferences

Oct 31, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Participate at Upcoming Investor Conferences

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 8:37 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 30, 2023, 4:05 PM EDT - 1 year ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 16, 2023, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Oct 10, 2023, 4:05 PM EDT - 1 year ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

Aug 6, 2023, 2:20 AM EDT - 2 years ago

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

Pulmonx Reports Second Quarter 2023 Financial Results

Aug 2, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Second Quarter 2023 Financial Results

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 26, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

Jul 17, 2023, 8:00 AM EDT - 2 years ago

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

Pulmonx: Entry To Japan Market Bullish For Zephyr Volumes (Rating Upgrade)

Jun 23, 2023, 8:52 AM EDT - 2 years ago

Pulmonx: Entry To Japan Market Bullish For Zephyr Volumes (Rating Upgrade)

Pulmonx Corporation (LUNG) Q1 2023 Earnings Call Transcript

May 2, 2023, 11:55 PM EDT - 2 years ago

Pulmonx Corporation (LUNG) Q1 2023 Earnings Call Transcript

Pulmonx Reports First Quarter 2023 Financial Results

May 2, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports First Quarter 2023 Financial Results

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Apr 25, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Apr 18, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

RocketThief
RocketThief Jul. 17 at 2:13 PM
$LUNG let her cook
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 16 at 9:35 PM
$LUNG earnings JULY 30
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 15 at 5:21 PM
$LUNG MASSIVE BID!!
0 · Reply
SAS080
SAS080 Jul. 14 at 6:36 PM
$LUNG added
0 · Reply
Jpextreme1
Jpextreme1 Jul. 14 at 4:53 PM
$LUNG Adds
0 · Reply
Raxothus
Raxothus Jul. 14 at 3:21 PM
EOD FOLLOW-UP – 07/14/25 Tracking continuation watch from 07/11 based on today’s highs vs prior close ✅ $DARE – Closed 2.51, hit 10.40 HOD ✅ $UAVS – Closed 1.57, hit 1.85 HOD ✅ $ZENA – Closed 5.03, hit 5.67 HOD ✅ $LUNG – Closed 2.91, hit 3.09 HOD ❌ $NMI – Closed 10.56, hit 10.49 HOD, then faded Recap Total: 5 Winners: 4 Faders: 1 Accuracy: 80% Strong continuation across the board Four out of five delivered clean range with volume Setups rewarded VWAP prep and patience from the prior session It won’t always be this clean — but we prep with purpose, wait for structure, and let the edge play out No guessing, no hope trades — just sniper-level execution #VWAP #SniperSetup #Continuation #SmallCaps #Accountability #DayTrading
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 14 at 1:00 PM
$LUNG looking to cross $3.00 soon with $3.12 the next major resistance🚨🚨
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 13 at 1:36 PM
$LUNG some AERISEAL news would be huge
2 · Reply
RocketThief
RocketThief Jul. 11 at 8:39 PM
$LUNG stay tuned
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 11 at 8:18 PM
$LUNG sec filings from Ferrari just hit
0 · Reply
making_money81
making_money81 Jul. 11 at 8:04 PM
$LUNG big volume spike today. Let’s see where this goes.
0 · Reply
Raxothus
Raxothus Jul. 11 at 7:39 PM
EOD CONTINUATION WATCHLIST – 07/11/25 Focused on volume, VWAP strength, and potential premarket continuation $DARE - Micro float with FDA momentum, 17.2% VWAP stretch, 9.5x volume, RSI 45.7. Top watch for continuation over 1.50 $UAVS - Small float, ISO certification + FAA catalyst, 14.6x volume, clean 11.3% move. Needs reclaim of 1.40 $ZENA - Defense spending tailwind, 3.1x volume, held VWAP late. Watching reclaim over 4.90 $LUNG - No fresh news, but 8.4% VWAP stretch with 4.5x volume. RSI 73.2. Needs clean open over 13 $NMI - No known catalyst. Technical setup only. RSI hot (72.8), 2.4% VWAP diff. Needs volume to confirm Looking for gap and VWAP hold tomorrow No volume no entry #VWAP #Continuation #SmallCaps #DayTrading #SniperSetup
1 · Reply
SNelson86
SNelson86 Jul. 7 at 4:05 PM
$LUNG
0 · Reply
RocketThief
RocketThief Jul. 2 at 5:32 PM
$LUNG what now, fourth time these clowns have changed their PT in 2025? 🤡
1 · Reply
JarvisFlow
JarvisFlow Jul. 2 at 10:30 AM
Citigroup has adjusted their stance on Pulmonx ( $LUNG ), setting the rating to Neutral with a target price of 7.5 → 8.
0 · Reply
RocketThief
RocketThief Jul. 1 at 3:08 PM
$LUNG this will run big randomly, just like it fell to $2S randomly
0 · Reply
VitalBull
VitalBull Jun. 20 at 8:58 PM
$LUNG What's going on here? No news. Hmmmm
0 · Reply
RocketThief
RocketThief Jun. 12 at 5:54 PM
$LUNG pathetic volume, there’s the LUNG I know and love. Added
0 · Reply
Whizz2k1
Whizz2k1 Jun. 12 at 3:52 AM
$LUNG https://www.investing.com/news/transcripts/pulmonx-at-goldman-sachs-conference-strategic-growth-insights-93CH-4091529 Pulmonx at Goldman Sachs Conference: Strategic Growth Insights Wednesday, the 11th of June 2025, Pulmonx Corp (NASDAQ:LUNG) presented its strategic vision at the Goldman Sachs 46th Annual Global Healthcare Conference. The company outlined its market position, financial performance, and future growth strategies, highlighting both opportunities and challenges in the evolving healthcare landscape. -Pulmonx targets a $12 billion total addressable market for severe emphysema. -The company reported 22% revenue growth last year, with a strong cash position of $88.7 million. -Zephyr valve technology is central to Pulmonx's strategy, backed by strong clinical validation. -Geographic expansion plans include China and Japan, with significant market potential. The "acquire, test, and treat" strategy aims to bridge the gap between patient activation and procedures performed.
0 · Reply
Gettingtillywithit
Gettingtillywithit Jun. 9 at 4:36 PM
$LUNG see 6000 bid they never happen but DID RIGHT BEFORE INSIDER BUY
0 · Reply
Gettingtillywithit
Gettingtillywithit Jun. 9 at 3:25 PM
$LUNG they can talk about the fact they had an insider buy of decent size at the Goldman on the 11th
0 · Reply
Gettingtillywithit
Gettingtillywithit Jun. 6 at 5:49 PM
$LUNG something just occurred to me yesterday there were those big bids and as it turns out, it was an insider by well we’ve had a couple of the same big bids today which are completely abnormal. They never happen and they happened yesterday and today and I’m hoping that today is just another insider by.
0 · Reply